Dr. Yousef Zakharia, MD
Claim this profileUniversity of Iowa Hospitals and Clinics
Studies Skin Cancer
Studies Renal Cell Carcinoma
21 reported clinical trials
46 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
MC1R positive
2Renal Cell Carcinoma
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Yousef Zakharia, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Radium-223 + Cabozantinib
for Kidney Cancer with Bone Metastasis
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
More about Yousef Zakharia, MD
Clinical Trial Related6 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Yousef Zakharia, MD has experience with
- Pembrolizumab
- Docetaxel
- Cabozantinib
- Axitinib
- Avelumab
- Everolimus
Breakdown of trials Yousef Zakharia, MD has run
Skin Cancer
Renal Cell Carcinoma
Kidney Cancer
Melanoma
Transitional Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yousef Zakharia, MD specialize in?
Yousef Zakharia, MD focuses on Skin Cancer and Renal Cell Carcinoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Yousef Zakharia, MD currently recruiting for clinical trials?
Yes, Yousef Zakharia, MD is currently recruiting for 9 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Yousef Zakharia, MD has studied deeply?
Yes, Yousef Zakharia, MD has studied treatments such as Pembrolizumab, Docetaxel, Cabozantinib.
What is the best way to schedule an appointment with Yousef Zakharia, MD?
Apply for one of the trials that Yousef Zakharia, MD is conducting.
What is the office address of Yousef Zakharia, MD?
The office of Yousef Zakharia, MD is located at: University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa Hospitals and Clinics.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.